NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF
· Real-Time Price · USD
1.89
-0.03 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
1.86
-1.59%
After-hours: Aug 15, 2025, 07:47 PM EDT
NewGenIvf Income Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q4 2024 | Q3 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | May 31, 2021 |
Revenue | 4.27M | 2.99M | 1.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.06M | 2.15M | 1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.2M | 843.03K | 196.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -2.52M | -1.79M | -2.52M | -1.37M | -1.1M | -855.42K | -504.91K | -389.35K | -284.81K | -162.12K | -2.09K | -2.01K |
Interest Income | 509.41K | 957.36K | 1.52M | 2.11M | 1.92M | 1.56M | 1.01M | 415.56K | 100.68K | 6.53K | n/a | n/a |
Pretax Income | -1.4M | -772.82K | -690.36K | 739K | 820.3K | 706.27K | 500.65K | 26.21K | -184.13K | -155.59K | -2.09K | -2.01K |
Net Income | -955.84K | -762.34K | -690.36K | 739K | 820.3K | 706.27K | 501.15K | 26.71K | -183.63K | -155.09K | -2.09K | -2.01K |
Selling & General & Admin | 3.52M | 2.44M | 2.52M | 1.37M | 1.1M | 855.42K | 504.91K | 389.35K | 284.81K | 162.12K | 2.09K | 2.01K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.52M | 2.44M | 2.52M | 1.37M | 1.1M | 855.42K | 504.91K | 389.35K | 284.81K | 162.12K | 2.09K | 2.01K |
Interest Expense | 694.27K | 273.17K | 25.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.26M | 3.27M | 2.52M | 1.37M | 1.1M | 855.42K | 504.91K | 389.35K | 284.81K | 162.12K | 2.09K | 2.01K |
Income Tax Expense | -487K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 569.25K | 363.65K | 253.73K | 135.54K | 135.54K | 135.54K | 217.35K | 217.35K | 217.35K | 135.54K | 37.5M | 37.5M |
Shares Outstanding (Diluted) | 569.25K | 363.65K | 253.73K | 135.54K | 135.54K | 135.54K | 217.35K | 217.35K | 217.35K | 135.54K | 37.5M | 37.5M |
EPS (Basic) | 50.40 | 70.90 | 81.85 | 103.35 | 103.85 | 84.80 | 46.90 | -7.65 | -31.6 | -28.3 | -0.00 | -0.00 |
EPS (Diluted) | 50.40 | 70.90 | 81.85 | 103.35 | 103.85 | 84.80 | 46.90 | -7.65 | -31.6 | -28.3 | -0.00 | -0.00 |
EBITDA | 864.07K | 891.23K | 716.48K | 739K | 820.3K | 706.27K | 501.15K | 26.71K | -183.63K | -155.09K | -2.09K | -2.01K |
EBIT | 507.91K | 714.99K | 549.53K | 739K | 820.3K | 706.27K | 501.15K | 26.71K | -183.63K | -155.09K | -2.09K | -2.01K |
Depreciation & Amortization | 356.15K | 176.25K | 166.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |